FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PD5FMC6

Market Closed - Deutsche Boerse AG 15:20:26 2024-06-26 EDT
0.06 EUR -1.64% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-41.75%
1 month-41.18%
Date Price Change
24-06-26 0.06 -1.64%
24-06-25 0.061 -3.17%
24-06-24 0.063 +5.00%
24-06-21 0.06 -11.76%
24-06-20 0.068 +4.62%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 03:20 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD5FMC
ISINDE000PD5FMC6
Date issued 2021-12-08
Strike 35.67
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 74.93
Lowest since issue 0.058
Spread 0.002
Spread %3.23%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus